[Thrombelastographic studies made to objectify the effects of Grisaldon upon the process of coagulation (author's transl)].
Thrombelastographic studies of the mode of action of Grisaldon showed that this preparation, unlike the pure substance of acetylsalicylic acid, has no appreciable coagulation-accelerating and fibrin-stabilizing effects. In addition, it was possible to show that an antifibrinolytic effect of the p-oxybenzoic acid propyl ester (Grisaldon component), which has been described in the literature, is not produced.